These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 25318208)

  • 1. [Transparency in cooperation. Sensitivity has grown (interview by Helmut Laschet)].
    Fischer B; Jonitz G
    MMW Fortschr Med; 2014 Jul; 156(13):18-9. PubMed ID: 25318208
    [No Abstract]   [Full Text] [Related]  

  • 2. [Transparency codex of the VFA (Association of Research-Based Pharmaceutical Companies). Why cooperation should be visible].
    Laschet H
    MMW Fortschr Med; 2014 Jul; 156(13):20-1. PubMed ID: 25318209
    [No Abstract]   [Full Text] [Related]  

  • 3. [Are contacts with established radiologists punishable by law in the future?].
    Steinhäuser RT; Wigge P
    Rofo; 2011 Jan; 183(1):78-80. PubMed ID: 21229485
    [No Abstract]   [Full Text] [Related]  

  • 4. Transparency rules at the Cleveland Clinic.
    Lancet; 2008 Dec; 372(9655):2002. PubMed ID: 19070728
    [No Abstract]   [Full Text] [Related]  

  • 5. [Openness in the cooperation between physicians and private corporations].
    Jørgensen J; Djurhuus JC
    Ugeskr Laeger; 2003 Apr; 165(16):1642-5. PubMed ID: 12756817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Transparency alone is not sufficient for the management of conflicts of interest - pro].
    Lieb K
    Psychiatr Prax; 2015 Jan; 42(1):12-3. PubMed ID: 25585000
    [No Abstract]   [Full Text] [Related]  

  • 7. [Recommendations for behavior in collaboration between the pharmaceutical industry with physicians].
    ; ;
    Urologe A; 2005 Feb; 44(2):133-50. PubMed ID: 15791699
    [No Abstract]   [Full Text] [Related]  

  • 8. Falling out with pharma.
    Whitehead S
    Lancet; 2013 Mar; 381(9872):1096-7. PubMed ID: 23540851
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical trial results, physicians, and insider trading.
    Prentice RA
    J Leg Med; 1999 Jun; 20(2):195-222. PubMed ID: 10407617
    [No Abstract]   [Full Text] [Related]  

  • 10. Correspondence (letter to the editor): Search bias.
    Braschoss A
    Dtsch Arztebl Int; 2010 Sep; 107(38):671-2; author reply 673-4. PubMed ID: 20953260
    [No Abstract]   [Full Text] [Related]  

  • 11. Disability guideline, role conflicts, and treatment records.
    Edwards HB
    J Am Acad Psychiatry Law; 2009; 37(3):392-6. PubMed ID: 19767506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physicians and clinical trials. To avoid federal scrutiny, take care when determining fair market value.
    Morillo A
    Mod Healthc; 2013 Sep; 43(38):22. PubMed ID: 24340738
    [No Abstract]   [Full Text] [Related]  

  • 13. [Consequences of the German anticorruption law for sponsorship at university hospitals].
    Neubauer A
    Wien Med Wochenschr; 2002; 152(9-10):246-8. PubMed ID: 12094401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biased articles.
    Friedman JH
    Med Health R I; 2009 Mar; 92(3):70. PubMed ID: 19385378
    [No Abstract]   [Full Text] [Related]  

  • 15. FDA publishes conflict of interest rules for clinical trials. Food and Drug Administration.
    James JS
    AIDS Treat News; 1998 Mar; (No 290):8. PubMed ID: 11365123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correspondence (letter to the editor): National foundation.
    Freund M
    Dtsch Arztebl Int; 2010 Sep; 107(38):671; author reply 673-4. PubMed ID: 20953259
    [No Abstract]   [Full Text] [Related]  

  • 17. Industrial-academic research relationships: departmental collaborations.
    Lewin JS
    Radiology; 2009 Jan; 250(1):23-7. PubMed ID: 19092088
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmaceuticals and medical devices: business practices.
    Steiner DJ
    Issue Brief Health Policy Track Serv; 2013 Dec; ():1-36. PubMed ID: 24482889
    [No Abstract]   [Full Text] [Related]  

  • 19. Report: FDA exerts too little oversight of researchers' conflicts of interest.
    Kuehn BM
    JAMA; 2009 Feb; 301(7):709-10. PubMed ID: 19224741
    [No Abstract]   [Full Text] [Related]  

  • 20. Transparency lacking. Despite Sunshine Act rules, policies still an issue.
    Lee J
    Mod Healthc; 2013 Mar; 43(10):10-1. PubMed ID: 23593894
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.